Compound for modulating rlr, tlr, oas and/or oncostatin m pathways, use thereof for preparing a medicine, composition, method for modulating said pathways and method of treatment
Inventor
Butantan affiliation
Publication type
Patent
Language
English
Access rights
Restricted access
Appears in Collections:
Abstract
The invention falls within the fields of pharmaceutical sciences, immunology and methods of treatment of cancer Methods. More specifically, the invention relates to a compound for modulating one or more innate immune pathways selected from RLR, TLR, OAS and/or oncostatin M, said compound being amblyomin-X or peptides derived from amblyomin-X. Use of said compound for preparing medicines; a pharmaceutical composition comprising said compound, a method for modulating said pathways in vitro and a method of treatment are also described.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/4323
Issue Date
2022
Show full item record
The access to the publications deposited in this repository respects the licenses from journals and publishers.